MRKR - Marker Therapeutics Gets A 'Thumbs Up' April, 25 2021 06:56 AM Marker Therapeutics Inc. Today, we take an in-depth look at clinical-stage immuno-oncology company named Marker Therapeutics. The company has multiple 'shots on goal', heavy insider buying and recently addressed its funding needs. A full investment analysis follows in the paragraphs below. For further details see: Marker Therapeutics Gets A 'Thumbs Up'